[PDF] MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody,

mbs303MBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trialsBuy MBS303-B-AX-0RAA with extended same day shipping times. View datasheets, stock and pricing, or find other Resistor Fixed Single-Through Hole.